healthprotocol.wiki

matsui-k_2003_cohort_intravenous-prostaglandin-e1-reduces-monocyte-chemoattractant-protein-1-levels-in-peripheral-arterial-obstructive-disease

5 findings

Protocol
therapy-intravenous-prostaglandin-e1-daily-seven-day
Outcome
biomarker-endothelin-1-serum-picograms-per-milliliter-measured
n
8
effect
0
attribution
30
Protocol
therapy-intravenous-prostaglandin-e1-daily-seven-day
Outcome
biomarker-high-sensitivity-c-reactive-protein-serum-milligrams-per-liter-measured
n
8
effect
0
attribution
30
Protocol
therapy-intravenous-prostaglandin-e1-daily-seven-day
Outcome
biomarker-interleukin-6-serum-picograms-per-milliliter-measured
n
8
effect
0
attribution
30
Protocol
therapy-intravenous-prostaglandin-e1-daily-seven-day
Outcome
biomarker-mcp-1-serum-picograms-per-milliliter-measured
n
8
effect
50
attribution
30
Protocol
therapy-intravenous-prostaglandin-e1-daily-seven-day
Outcome
biomarker-von-willebrand-factor-activity-percent-measured
n
8
effect
0
attribution
30